Association of apolipoprotein E genotypes with serum lipid profiles in a healthy population of Taiwan

Annals of Clinical and Laboratory Science

Volumn 34, Issue 4, 2004, Pages 443-448

  Lin, Shu Kai ^a   Kao, Jau Tsuen ^b   Tsai, Shih Meng ^c   Tsai, Li Yu ^a,c   Lin, Mei Nung ^a   Lai, Chung Jen ^c   Zhong, Way Li ^c  

^a KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^c KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Apolipoproteins E, A I, B; Polymerase chain reaction restriction fragment length polymorphism

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN B; APOLIPOPROTEIN E; CYANOCOBALAMIN; FOLIC ACID; HOMOCYSTEINE; LIPID;

ALLELE; APOE EPSILON2 ALLELE; APOE EPSILON3 ALLELE; APOE EPSILON4 ALLELE; APOE GENE; ARTICLE; CORONARY ARTERY DISEASE; CORONARY RISK; GENE; GENE FREQUENCY; GENE FUNCTION; GENOTYPE; GENOTYPE PHENOTYPE CORRELATION; HUMAN; LIPID BLOOD LEVEL; LIPID TRANSPORT; LIPOPROTEIN METABOLISM; NORMAL HUMAN; POLYMERASE CHAIN REACTION; POPULATION GENETICS; PRIORITY JOURNAL; PROTEIN FUNCTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK FACTOR; TAIWAN;

APOLIPOPROTEINS E; CORONARY ARTERIOSCLEROSIS; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; LIPIDS; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; RISK FACTORS; TAIWAN;

EID: 11144311180     PISSN: 00917370     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Shaw DJ, Brook JD, Meredith AL, Harley HG, Safaris M. Harper PS. Gene mapping and chromosome 19. J Med Genet 1986;23:2-10.
2. Endives ES, Gordon DA, Pursing LK, Williams DL, Bachman LB. Systemic distribution of apolipoprotein E secreted by grafts of epidermal keratinocytes; implications for epidermal function and gene therapy. PNAS USA 1989;86:8803-8807.
3. de Knijff P, Maagdenberg AMJM, Frants RR, Havekes LM. Genetic heterogeneity of apolipoprotein E and its influence on plasma lipid and lipoprotein levels. Hum Mutat 1994;4:178-194.
4. Davignon J, Gregg RE, Sing CF. Apolipoprotein E polymorphism and arteriosclerosis. Arteriosclerosis 1988; 8:1-21.
5. Allen DR A model for susceptibility polymorphisms for complex diseases: apolipoprotein E and Alzheimer disease. Neurogenetics 1977;1:3-11.
6. Mahley RW, Rally SC. Type III hyperlipoproteinemia (dysbetalipoproteinemia): the role of apolipoprotein E in normal and abnormal lipoprotein metabolism. In: The Metabolic Basis of Inherited Disease, 6th ed (Scriver CR, Beaudet AL, Sly WS, Valle D, Eds), McGraw-Hill, New York, 1989; chap 6, pp 1195.
7. Gaubatz JW, Heideman C, Gotto AM Jr, Morris JD, Dahlen GM. Isolation and characterization of the two major apoproteins in human lipoprotein(a). J Biol Chem 1983;258:4582-4589.
8. Utermann G, Weber W. Protein composition of Lp(a) lipoprotein from human plasma. FEBS Lett 1983;154: 357-361.
9. von Hodenberg E, Kreuzer J, Hautmann M, Nordt T, Kubler W, Bode C. Effects of lipoprotein(a) on success rate of thrombolytic therapy in acute myocardial infraction. Am J Cardiol 1991;67:1349-1353.
10. Moliterno DJ, Lange RA, Meidell RS, Willard JE, Leffert CC, Gerard RD, Boerwinkle E, Hobbs HH, Hillis LD. Relation of plasma lipoprotein(a) to infarct artery potency in survivors of myocardial infraction. Circulation. 1993; 88:935-940.
11. Expert Panel, Summary of the second report of the National Cholesterol Education Panel (NCEP) expert panel on detection, evaluation and treatment of high blood cholesterol in adults (Adults Treatment Panel II). JAMA 1993;269:3015-3023.
12. Maciejko JJ, Holmes DR, Kottke BA, Zinsmeister AR. Dinh DM, Mao STJ. Apolipoprotein A-I as a marker of angiographically assessed coronary-artery disease. N Engl J Med 1983;309:385-389.
13. Tasaki H, Nakashima Y, Nandate H, Yashiro A, Kawashima T, Kuroiwa A. Comparison of serum lipid values in variant angina pectoris and fixed coronary artery disease with normal subjects. Am J Cardiol 1989;63:1441-1445.
14. Reinhart RA Gani K, Arndt MR, Broste SK. Apolipoproteins A-I, B as predictors of angiographically defined coronary heart disease. Arch Intern Med 1990;150:1629-1633.
15. Graziani MS, Zanolla L, Righetti G, Marchetti C, Mocarelli P, Marcovina SM. Plasma apolipoproteins A-I and B in survivors of myocardial infarction and in a control group. Clin Chem 1998;44:134-140.
16. Noma A, Yokosuka T, Kitamura K. Plasma lipids and apolipoproteins as discriminators for presence and severity of angiographically defined coronary artery disease. Atherosclerosis 1983;49:1-7.
17. Shen X, Xia Y, Sass C, Visvikis S, Siest C. Association of apolipoprotein E polymorphism and concentration with serum lipids and apolipoprotein level in Chinese from Shanghai. Clin Chem Lab Med 1998;36:615-619.
18. Wu JH, Lo SK, Wen MS, Kao JT. Characterization of apolipoprotein E genetic variation with coronary heart disease and plasma lipid levels. Hum Biol 2002;74:25-31.
19. Kao JT, Tsai KS, Chang CJ, Huang PC. The effects of apolipoprotein E polymorphism on the distribution of lipids and lipoprotein in the Chinese population. Atherosclerosis 1995;114:55-59.
20. Davignon J, Gregg RE, Sing CF. Apolipoprotein E polymorphism and atherosclerosis. Arteriosclerosis 1988;8:1-21.
21. Menzel HJ, Kladetsky RG, Assmann G. Apolipoprotein E polymorphism and coronary artery disease. Arteriosclerosis 1983;3:310-315.
22. Bouthillier D, Sing CF, Davignon J. Apolipoprotein E phenotyping with a single gel method: application to the study of informative matings. J Lipid Res 1983;24:1060-1069.
23. Wilson HM, Patel JC, Russel D, Skinner ER. Alterations in the concentration of an apolipoprotein E-containing subfraction of plasma high density lipoprotein in coronary heart disease. Clin Chim Acta 1993;220:175-187.
24. Ikewaki K, Rader DJ, Zech LA, Brewer HB Jr. In vivo metabolism of apolipoprotein A-I and E in patients with abetalipoproteinemia: implications for the roles of apolipoproteins B and E in HDL metabolism. J Lipid Res 1994;35:1809-1819.
25. Schaefer EJ, Lamon-Fave S, Johnson S, Ordovas JM, Schaefer MM, Castelli WP. Effects of gender and menopausal status on the association of apolipoprotein E phenotype with plasma lipoprotein levels. Results from Framingham Offspring Study. Arterioscler Throm 1994; 14:105-113.
26. Srinivasan SR, Ehnholm C, Elkasabany A, Berenson G. Influence of apolipoprotein E polymorphism on serum lipids and lipoprotein changes from childhood. The Bogalusa Heart Study. Atherosclerosis 1999;143:435-443.
27. Corbo MR, Viraldo T, Ruggeri M, Gemma AT, Scacchi R. Apolipoprotein E genotype and plasma levels in coronary artery disease. A case control study in the Italian population. Clin Biochem 1999;32:217-222.
28. Luc G, Bard JM, Arveiler D, Evans A, Cambou JP, Bingham A, Amouyel P, Schaffer P, Ruidavets JB, Cambien F. Impact of apolipoprotein E polymorphism on lipoproteins and risk of myocardial infarction. The ECTIM study. Arterioscler Thromb 1994;14:1412-1419.
29. Gulen A, Esmeray A, Gulcin E, Onur A, Abdullah T, Mehmet K, Levent K. Effects of apolipoprotein E genotypes and other risk factors on the development of coronary artery disease in Southern Turkey. Clin Chim Acta 2001;312:191-196.
30. Hsueh WC, Mitchell BD, Hixson JE, Rainwater DL. Effects of the polymorphism on plasma lipoproteins in Mexican Americans. Ann Epidemiol 2000;10:524-531.
31. Hergenc G, Taga Y, Emerk K, Cirakoglu B. Apolipoprotein E genotyping in Turkish myocardial infarction survivors and healthy controls. J Biomed Sci 1995;2:46-49.
32. Gamboa R, Vargas AG, Medina UA, Cardoso SG, Hernandez PG, Zamora GJ, Posadas RC. Influence of the apolipoprotein E polymorphism on plasma lipoproteins in a Mexican population. Hum Biol 2001; 73:835-843.
33. Kumar T, Liestol K, Maehlen A, Jettestuen E, Lind H, Brorson SH. Allele frequencies of apolipoprotein E gen polymorphisms in the protein coding region and promoter region (-491A/T) in a healthy Norwegian population. Hum Biol 2002;74:137-142.
34. Petrovic D, Zorc M, Peterlin B. Effect of apolipoprotein E polymorphism and apolipoprotein A-I gene promoter polymorphism on lipid parameters and premature coronary artery disease. Folia Biol (Prague) 2000;46:181-185.
35. Thelma BK, Juyal RC, Dodge HH, Pandav R, Chandra V, Ganguli M. Polymorphism in a rural older population-based sample in India. Hum Biol 2001;73:135-144.
36. Singh P, Singh M, Gerdes U, Mastana SS. Apolipoprotein E polymorphism in India: high E3 allele frequency in Ramgarhia of Punjab. Anthropol Anz 2001;59:27-34.
37. Sanja S, Sanja G, Deagan A. The effect of a gender difference in the apolipoprotein E gene DNA polymorphism on serum lipid levels in Serbian healthy population. Clin Chem Lab Med 2000;38:539-544.